Your browser doesn't support javascript.
loading
Blockade of human P2X7 receptor function with a monoclonal antibody.
Buell, G; Chessell, I P; Michel, A D; Collo, G; Salazzo, M; Herren, S; Gretener, D; Grahames, C; Kaur, R; Kosco-Vilbois, M H; Humphrey, P P.
Afiliação
  • Buell G; Glaxo Institute for Molecular Biology, Geneva, Switzerland; and the Glaxo Institute for Applied Pharmacology, Department of Pharmacology, University of Cambridge, Cambridge, UK.
Blood ; 92(10): 3521-8, 1998 Nov 15.
Article em En | MEDLINE | ID: mdl-9808543
ABSTRACT
A monoclonal antibody (MoAb) specific for the human P2X7 receptor was generated in mice. As assessed by flow cytometry, the MoAb labeled human blood-derived macrophage cells natively expressing P2X7 receptors and cells transfected with human P2X7 but not other P2X receptor types. The MoAb was used to immunoprecipitate the human P2X7 receptor protein, and in immunohistochemical studies on human lymphoid tissue, P2X7 receptor labeling was observed within discrete areas of the marginal zone of human tonsil sections. The antibody also acted as a selective antagonist of human P2X7 receptors in several functional studies. Thus, whole cell currents, elicited by the brief application of 2',3'-(4-benzoyl)-benzoyl-ATP in cells expressing human P2X7, were reduced in amplitude by the presence of the MoAb. Furthermore, preincubation of human monocytic THP-1 cells with the MoAb antagonized the ability of P2X7 agonists to induce the release of interleukin-1beta.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas do Receptor Purinérgico P2 / Anticorpos Monoclonais Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 1998 Tipo de documento: Article País de afiliação: Reino Unido
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas do Receptor Purinérgico P2 / Anticorpos Monoclonais Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 1998 Tipo de documento: Article País de afiliação: Reino Unido